x
Filter:
Filters applied
- Oncology
Publication Date
Please choose a date range between 2016 and 2020.
Author
- Boorjian, Stephen A11
- Thompson, R Houston10
- Andriole, Gerald L9
- Kim, Eric H8
- Leibovich, Bradley C8
- Vetter, Joel M8
- Daneshmand, Siamak7
- Shetty, Anup S7
- Djaladat, Hooman6
- Lepor, Herbert6
- Abel, E Jason5
- Briganti, Alberto5
- Carver, Brett S5
- Allaf, Mohamad E4
- Campbell, Steven C4
- Freedland, Stephen J4
- Kutikov, Alexander4
- Lane, Brian R4
- Master, Viraj A4
- Anderson, Christopher B3
- Assel, Melissa3
- Cooperberg, Matthew R3
- Liss, Michael A3
- Syed, Jamil S3
- Allen, Glenn O2
Keyword
- acute kidney injury1
- AKI1
- American Society of Anesthesiology1
- ASA1
- CHF1
- chronic obstructive pulmonary disease1
- CI1
- confidence interval1
- congestive heart failure1
- COPD1
- CPT1
- current procedural erminology1
- HTN1
- hypertension1
- interquartile range1
- IQR1
- length of stay1
- LOS1
- National Surgical Quality Improvement Program1
- NMIBC1
- NSQIP1
- OR1
- RF1
- TURBT1
- UTI1
Oncology
276 Results
- Oncology
The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study
UrologyVol. 148p185–191Published online: December 4, 2020- Dhaval Jivanji
- Scott Jamieson
- Chase Mallory
- Vivian Wong
- Sidney Barrau
- Elias Atri
- and others
Cited in Scopus: 2To determine if race was associated with 5-year cause-specific survival in patients with clear cell renal cell carcinoma. - Oncology
Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer
UrologyVol. 148p203–210Published online: November 6, 2020- Jacob W. Greenberg
- Gabriel Leinwand
- Allison H. Feibus
- Nora M. Haney
- L. Spencer Krane
- Raju Thomas
- and others
Cited in Scopus: 4To evaluate the risk upgrading of active surveillance (AS), we reviewed the outcomes of African American men (AA) after electing AS. AS is the standard of care for men with low-grade prostate cancer (PCa). AA are known to have more advanced PCa features and are more likely to die from PCa, thus subsequent disease progression for AA on AS is unclear. - Genomics
Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
UrologyVol. 147p119–126Published online: October 30, 2020- Brian Halbert
- David J. Einstein
Cited in Scopus: 10Pembrolizumab was recently approved for treatment of cancers with high tumor mutational burden (TMB). We conduct a focused literature review of TMB as a predictive biomarker. TMB quantifies the sum of nonsynonymous coding mutations (typically single nucleotide substitutions and short insertion-deletions) per megabase of sequenced DNA. As a proxy for expression of immunogenic neoantigens, TMB may be an effective predictive biomarker for response to immune checkpoint inhibitors. However, like other biomarkers in this setting, TMB has many limitations; the effect of this FDA approval in the current management of genitourinary cancers is likely limited to select situations. - Oncology
Testis-sparing Surgery: A Single Institution Experience
UrologyVol. 147p192–198Published online: October 30, 2020- Jillian Egan
- Joseph G. Cheaib
- Michael J. Biles
- Mitchell M. Huang
- Meredith Metcalf
- Andres Matoso
- and others
Cited in Scopus: 4To demonstrate the safety and efficacy of testis-sparing surgery (TSS) in 2 specific circumstances: small, nonpalpable masses suspected to be benign and masses suspicious for germ cell tumor in a solitary or functionally solitary testicle or bilateral disease. - Oncology
Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification
UrologyVol. 147p205–212Published online: October 28, 2020- Timo F.W. Soeterik
- Harm H.E van Melick
- Lea M. Dijksman
- Douwe H. Biesma
- J. Alfred Witjes
- Jean-Paul A. van Basten
Cited in Scopus: 9To assess the impact of multiparametric magnetic resonance imaging (mp-MRI) local tumor staging on prostate cancer risk stratification and choice of treatment. - Oncology
A Contemporary Analysis of the 30-day Morbidity and Mortality Associated With Cytoreductive Nephrectomy
UrologyVol. 147p186–191Published online: October 23, 2020- Danica N. May
- Hayden Hill
- Marc R. Matrana
- Kathleen Lata-Arias
- Daniel J. Canter
Cited in Scopus: 4To examine the rates of adverse surgical outcomes in patients undergoing cytoreductive nephrectomy (CN) compared to patients undergoing radical nephrectomy in the nonmetastatic setting using a large administrative database. - Oncology
Early Effects of High-intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer on Fecal Continence and Anorectal Physiology
UrologyVol. 148p211–216Published online: October 16, 2020- Renato Vasconcelos Souza de Almeida
- José Ricardo Cruz Silvino
- Jamile Rosario Kalil
- Vitor Lazarini dos Santos Jr
- Vinicius Meneguette Gomes de Souza
- Jose Pontes Jr
- and others
Cited in Scopus: 0To evaluate high-intensity focused ultrasound (HIFU) effects on anorectal physiology and fecal continence or constipation, and on quality of life (QoL). - Oncology
Contemporary Trends in Presentation and Management of Spermatocytic Seminoma
UrologyVol. 146p177–182Published online: October 10, 2020- Parth M. Patel
- Hiten D. Patel
- Elizabeth L. Koehne
- Chirag Doshi
- Alex Belshoff
- Christopher M. Seffren
- and others
Cited in Scopus: 2To characterize the presentation and management of spermatocytic seminoma (SS) compared to classic seminoma in adults utilizing a large cancer registry. - Oncology
Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation
UrologyVol. 148p198–202Published online: September 23, 2020- April Vassantachart
- Siamak Daneshmand
- Jie Cai
- Gus Miranda
- Saum Ghodoussipour
- Anne K. Schuckman
- and others
Cited in Scopus: 1To evaluate the complications and oncologic outcomes of orthotopic ileal neobladder reconstruction (ONB) following pelvic radiotherapy (RT) compared to patients with no prior pelvic RT. - Covid-19
Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic
UrologyVol. 147p50–56Published online: September 20, 2020- Kevin B. Ginsburg
- Gannon L. Curtis
- Devin N. Patel
- Wen Min Chen
- Marshall C. Strother
- Alexander Kutikov
- and others
Cited in Scopus: 9To test for an association between surgical delay and overall survival (OS) for patients with T2 renal masses. Many health care systems are balancing resources to manage the current COVID-19 pandemic, which may result in surgical delay for patients with large renal masses. - Oncology
Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance
UrologyVol. 147p213–222Published online: September 15, 2020- Kevin B Ginsburg
- Jesse C Jacobs
- Ji Qi
- Deborah R Kaye
- Susan S Eggly
- Susan M Linsell
- and others
Cited in Scopus: 5To assess the impact of confirmatory tests on active surveillance (AS) biopsy disease reclassification and progression to treatment in men with favorable risk prostate cancer (FRPC). - Oncology
Post Prostatectomy Pathologic Findings of Patients With Clinically Significant Prostate Cancer and no Significant PI-RADS Lesions on Preoperative Magnetic Resonance Imaging
UrologyVol. 146p183–188Published online: September 15, 2020- Shaheen Alanee
- Mustafa Deebajah
- Kanika Taneja
- Daniel Cole
- Milan Pantelic
- James Peabody
- and others
Cited in Scopus: 2We present postprostatectomy pathology results from a series of prostate cancer (Pca) Gleason grade group ≥2 patients who did not have findings suggestive of cancer on preoperative pelvic magnetic resonance imaging (MRI). - Oncology
Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis
UrologyVol. 146p158–167Published online: September 3, 2020- Aleem I. Khan
- Benjamin L. Taylor
- Bashir Al Hussein Al Awamlh
- Lina Posada Calderon
- Jonathan Fainberg
- Rahmi Elahjji
- and others
Cited in Scopus: 3To assess the impact of neoadjuvant chemotherapy (NAC) on survival outcomes in a contemporary cohort of patients with in upper tract urothelial carcinoma (UTUC). - Oncology
Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience
UrologyVol. 147p223–229Published online: September 3, 2020- Mitchell M. Huang
- Hiten D. Patel
- Julia J. Wainger
- Zhuo T. Su
- Russell E.N. Becker
- Misop Han
- and others
Cited in Scopus: 11To perform an early comparative study of outcomes between single-port and robot-assisted laparoscopic radical prostatectomy (SP-RALRP) and standard RALRP at our institution and pooled analysis of series to date. - Oncology
Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies
UrologyVol. 146p189–195Published online: September 1, 2020- Maria F. Becerra
- Mahmoud Alameddine
- Isaac Zucker
- Leonardo Tamariz
- Ana Palacio
- Zsuzsanna Nemeth
- and others
Cited in Scopus: 4To assess the outcomes through systematic review and meta-analysis of multi-parametric magnetic resonance imaging (mpMRI) of the prostate in biopsy naïve men. - Oncology
Comparison of Major Complications at 30 and 90 Days Following Radical Cystectomy
UrologyVol. 148p192–197Published online: September 1, 2020- Jacob M. Knorr
- Kyle J. Ericson
- JJ H. Zhang
- Prithvi Murthy
- Amy S. Nowacki
- Carlos Munoz-Lopez
- and others
Cited in Scopus: 8To better understand the time-course in which major complications occur after radical cystectomy and to describe associations with complications at 30 and 90 days. - Oncology
Suboptimal Prediction of Clinically Significant Prostate Cancer in Radical Prostatectomy Specimens by mpMRI-Targeted Biopsy
UrologyVol. 148p217–223Published online: August 29, 2020- Nejdet Karsiyakali
- Mahir Bulent Ozgen
- Bora Ozveren
- Cem Akbal
- Alp Dincer
- Haydar Durak
- and others
Cited in Scopus: 0To investigate the correlation of multiparametric magnetic resonance imaging targeted (TBx) and/or systematic prostate biopsy (SBx) in predicting the presence of clinically significant (cs) prostate cancer (PCa) in radical prostatectomy (RP) specimens. Concordance of mpMRI and RP specimen lesions was also investigated in terms of tumor localization and histopathological features. - Oncology
Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database
UrologyVol. 146p168–176Published online: August 28, 2020- Christina Darwish
- Andrew Sparks
- Richard Amdur
- Akshay Reddy
- Michael Whalen
Cited in Scopus: 4To utilize a national dataset to compare outcomes and demonstrate trends in treatment for lymph node positive bladder cancer (N+ BC). - Oncology
Feasibility and Safety of Robotic Excision of Ipsilateral Retroperitoneal Recurrence After Nephrectomy for Renal Cell Carcinoma
UrologyVol. 145p159–165Published online: August 20, 2020- Rashed Ghandour
- Andre Filipe Miranda
- Nirmish Singla
- Xiaosong Meng
- Dmitry Enikeev
- Solomon Woldu
- and others
Cited in Scopus: 4To determine feasibility and safety of robotic excision of local ipsilateral recurrences after nephrectomy for renal cell carcinoma (RCC). Surgical resection is an option for treatment of low burden locally recurrent RCC, potentially delaying the use of systemic therapy. This has historically been performed by open technique, which can impart significant morbidity. We present our experience with robotic excision. - Oncology
Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?
UrologyVol. 147p199–204Published online: August 13, 2020- Karl H. Tully
- Alexander P. Cole
- Marieke J. Krimphove
- David F. Friedlander
- Matthew Mossanen
- Peter Herzog
- and others
Cited in Scopus: 6To examine recent treatment trends for non-muscle-invasive bladder cancer (NMIBC), and specifically, to assess whether there was a change in use radical cystectomy (RC) between 2008 and 2015 using data from the Surveillance, Epidemiology, and End Results database. - Oncology
The Remaining Ipsilateral Ureteral Orifice Provokes Intravesical Tumor Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Study With a Mid-Term Follow-Up
UrologyVol. 145p166–171Published online: August 10, 2020- Se Yun Kwon
- Young Hwii Ko
- Phil Hyun Song
- Byung Hoon Kim
- Bum Soo Kim
- Tae-Hwan Kim
- and others
Cited in Scopus: 1To investigate the impact of the remnant ureteral orifice (RUO) on the prognosis of upper tract urothelial carcinoma (UTUC), because the presence of an ipsilateral intact ureteral orifice is not an uncommon finding during follow-up cystoscopy despite the clinical relevance of bladder cuffing during radical nephroureterectomy (RNU) for the management of UTUC. - Oncology
Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
UrologyVol. 146p152–157Published online: August 8, 2020- Leo D. Dreyfuss
- Viraj A. Master
- Jay D. Raman
- Philippe E. Spiess
- Shane A. Wells
- Suzanne B. Merrill
- and others
Cited in Scopus: 0To evaluate postoperative recurrence patterns for high-risk nonmetastatic renal cell carcinoma (RCC) and to identify prognostic factors associated with site-specific metastatic recurrence using a multi-institutional contemporary cohort. - Oncology
Overtreatment and Underutilization of Watchful Waiting in Men With Limited Life Expectancy: An Analysis of the Michigan Urological Surgery Improvement Collaborative Registry
UrologyVol. 145p190–196Published online: August 7, 2020- Udit Singhal
- Jeffrey J. Tosoian
- Ji Qi
- David C. Miller
- Susan M. Linsell
- Michael Cher
- and others
Cited in Scopus: 4To determine rates of watchful waiting (WW) vs treatment in prostate cancer (PCa) and limited life expectancy (LE) and assess determinants of management. - Oncology
Risk of Genitourinary Malignancy in the Renal Transplant Patient
UrologyVol. 145p152–158Published online: August 4, 2020- Song Jiang
- Subodh Regmi
- Scott Jackson
- Collin Calvert
- Stephanie Jarosek
- Timothy Pruett
- and others
Cited in Scopus: 3To better understand the risk of genitourinary malignancies in the renal transplant patient. Currently, no consensus exists regarding screening and intervention, with much of the clinical decision-making based on historical practices established before recent progress in immunosuppression protocols and in genitourinary cancer diagnosis and management. - Oncology
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making
UrologyVol. 145p197–203Published online: August 3, 2020- Nayan Lamba
- Santino Butler
- Brandon A. Mahal
- Quoc-Dien Trinh
- Brent Rose
- Martin King
- and others
Cited in Scopus: 0To inform treatment decisions for patients with high-risk prostate cancer (PCa), we determined rates of adverse pathologic factors and overall survival (OS) among subgroups of high-risk men.